iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding iSpecimen Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 13 | 1 | 6 | −6 |
| Shares | 334.4K | 56.5K | 38.9K | −238.9K (−86.0%) |
| Value | $103.1K | $17.5K | $182.9K | +$97.2K (+113.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held iSpecimen Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 11,500 | $54.0K | 0.03% |
| BlackRock, Inc. | 2,827 | $13.3K | 0.00% |
| UBS Group AG | 1,469 | $6.90K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,168 | $5.49K | 0.00% |
Sold out (10)
Institutions that held iSpecimen Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| HRT Financial LP | 45,935 | $14.0K |
| Virtu Financial LLC | 42,087 | $13.0K |
| Geode Capital Management, LLC | 38,498 | $11.9K |
| Vanguard Group Inc | 35,987 | $11.1K |
| Grimes & Company, Inc. | 30,818 | $9.52K |
| Citadel Advisors LLC | 25,500 | $7.88K |
| StoneX Group Inc. | 14,742 | $4.55K |
| Northern Trust Corp | 13,805 | $4.27K |
| Main Street Financial Solutions, LLC | 10,500 | $3.25K |
| Sachetta, LLC | 22 | $6 |
Not filed for Q3 2024 yet (1)
Institutions that held iSpecimen Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 56,538 | $17.5K |